In fact, only 12 of the 133 new drug trials approved by the DOH in 2006 were Phase 1 trials. In addition, only one of the 92 hospitals approved for human trials by the Joint Institutional Review Board carried out Phase 1 trials in 2006.
2006 年向衛生署藥政處申請的 133 件新藥人體試驗中，屬於第一期的只有 12 件，佔總數不到一成；在 92 家醫院認可的「聯合人體試驗委員會」（JIRB）的審查統計上，2006 年更只有一件，佔當年度件數的 1％不到。